Synthesizing peptides — the chains of amino acids that conduct various functions within cells — has long been a research area of interest for scientists and engineers. There has however been little success thus far, as existing methods for synthesizing peptides have been prohibitively expensive and time-consuming.
If you are familiar with the biotech industry, you know Cambridge. The small city at the center of the Great Boston Area hosts over 1,000 biotechnology-related companies. Most of these companies cluster around Kendall Square, the same block as the Massachusetts Institute of Technology (MIT).
Chinese media is reporting that several domestic brokers and investment banks were recently informed by the China Securities Regulatory Commission (CSRC) that it will relax regulations on prospectus approval time and profitability minimums for Chinese unicorns in the domains of artificial intelligence, cloud computing, biotech, and high-end manufacturing.